GLIPR1 and Wilms tumor: Epigenetic modulation of GLIPR1 expression by promoter methylation has been reported previously in prostate cancer, glioma, and Wilms’ tumors, and we show that it is also the case in melanoma cells in the samples tested, with decreasing promoter methylation associated with increasing levels of GLIPR1.